1. bookTom 26 (2015): Zeszyt 7 (September 2015)
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2719-9509
Pierwsze wydanie
01 Jan 1992
Częstotliwość wydawania
4 razy w roku
Języki
Angielski
Otwarty dostęp

Implications of Evolving Medical Science for Proof of Lung Cancer Causation

Data publikacji: 20 Oct 2015
Tom & Zeszyt: Tom 26 (2015) - Zeszyt 7 (September 2015)
Zakres stron: 298 - 311
Otrzymano: 09 Apr 2014
Przyjęty: 26 Aug 2015
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2719-9509
Pierwsze wydanie
01 Jan 1992
Częstotliwość wydawania
4 razy w roku
Języki
Angielski

1. Hanahan, D. and R.A. Weinberg: The Hallmarks of Cancer; Cell 100 (2000) 57-70.Search in Google Scholar

2. Vogelstein, B., N. Papadopoulos, V.E. Velculescu, S. Zhou, L.A. Diaz, Jr, and K.W. Kinzler: Cancer Genome Landscapes; Science 339 (2013) 1546-1558.Search in Google Scholar

3. Raparia, K., C. Villa, M.M. DeCamp, J.D. Patel, and M.P. Mehta: Molecular Profiling in Non-Small Cell Lung Cancer: A Step Toward Personalized Medicine; Arch. Pathol. Lab. Med. 137 (2013) 481-491.Search in Google Scholar

4. Rosai, J.: Rosai and Ackerman’s Surgical Pathology, 9th ed., Mosby, Edinburgh, UK, 2004.Search in Google Scholar

5. Coolidge v. Philip Morris Inc., RIC361063 Superior Court of California, Riverside County, Dept. 6 (2005).Search in Google Scholar

6. Khuder, S.A.: Effect of Cigarette Smoking on Major Histological Types of Lung Cancer: A Meta-Analysis; Lung Cancer 31 (2001) 139-148.Search in Google Scholar

7. Rudin, C.M., E. Avila-Tang, C.C. Harris, J.G. Herman, F.R. Hirsch, W. Pao, A.G. Schwartz, K.H. Vahakangas, and J.M. Samet: Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications; Clin.Cancer Res. 15 (2009) 5646-5661.Search in Google Scholar

8. Pesch, B., B. Kendzia, P. Gustavsson, K.-H. Jöckel, G.Johnen, H. Pohlabeln, A. Olsson, W. Ahrens, I.M.Gross, I. Brüske, H.-E. Wichmann, F. Merletti, L.Richiardi, L. Simonato, C. Fortes, J. Siemiatycki, M.-E.Parent, D. Consonni, M.T. Landi, N. Caporaso, D.Zaridze, A. Cassidy, N. Szeszenia-Dabrowska, P. Rudnai, J. Lissowska, I. Stücker, E. Fabianova, R.S.Dumitru, V. Bencko, L. Foretova, V. Janout, C.M.Rudin, P. Brennan, P. Boffetta, K. Straif, and T.Brüning: Cigarette Smoking and Lung Cancer- Relative Risk Estimates for the Major Histological Types from a Pooled Analysis of Case-Control Studies; Int. J. Cancer 131 (2012) 1210-1219.Search in Google Scholar

9. Devesa, S.S., F. Bray, A.P. Vizcaino, and D.M. Parkin: International Lung Cancer Trends by Histologic Type: Male:Female Differences Diminishing and Adeno- carcinoma Rates Rising; Int. J. Cancer 117 (2005) 294-299.Search in Google Scholar

10. Doll, R., A.B. Hill, and L. Kreyberg: The Significance of Cell Type in Relation to the Aetiology of Lung Cancer; Br. J. Cancer 11 (1957) 43-48.Search in Google Scholar

11. Travis, W.D., E. Brambilla, M. Noguchi, A.G. Nicholson, K.R. Geisinger, Y. Yatabe, D.G. Beer, C.A. Powell, G.J. Riely, P.E. Van Schil, K. Garg, J.H.M Austin, H. Asamura, V.W. Rusch, F.R. Hirsch, G. Scagliotti, T. Mitsudomi, R.M. Huber, Y. Ishikawa, J.Jett, M. Sanchez-Cespedes, J.-P. Sculier, T. Takahashi, M. Tsuboi, J. Vansteenkiste, I.I. Wistuba, P.-C. Yang, D. Aberle, C. Brambilla, D. Flieder, W. Franklin, A. Gazdar, M. Gould, P. Hasleton, D. Henderson, B.Johnson, D. Johnson, K. Kerr, K. Kuriyama, J.S. Lee, V.A. Miller, I. Petersen, V. Roggli, R. Rosell, N. Saijo, E. Thunnissen, M. Tsao, and D. Yankelewitz: International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma; J. Thorac. Oncol. 6 (2011) 244-285.Search in Google Scholar

12. Thun, M.J., C.A. Lally, J.T. Flannery, E.E. Calle, W.D. Flanders, and C.W. Heath, Jr: Cigarette Smoking and Changes in the Histopathology of Lung Cancer; J. Natl. Cancer Inst. 89 (1997) 1580-1586.Search in Google Scholar

13. Burns, D.M., C.M. Anderson, and N. Gray: Do Changes in Cigarette Design Influence the Rise in Adenocarcinoma of the Lung?; Cancer Causes Control 22 (2011) 13-22.Search in Google Scholar

14. Brooks, D.R., J.H.M. Austin, R.T. Heelan, M.S. Ginsberg, V. Shin, S.H. Olson, J.E. Muscat, and S.D. Stellman: Influence of Type of Cigarette on Peripheral versus Central Lung Cancer; Cancer Epidemiol. Biomarkers Prev. 14 (2005) 576-581.Search in Google Scholar

15. Chen, F., P. Cole, and W.F. Bina: Time Trend and Geographic Patterns of Lung Adenocarcinoma in the United States, 1973-2002; Cancer Epidemiol. Biomarkers Prev. 16 (2007) 2724-2729.Search in Google Scholar

16. Fry, J.S., P.N. Lee, B.A. Forey, and K.J. Coombs: Is The Shape of the Decline in Risk Following Quitting Smoking Similar for Squamous Cell Carcinoma and Adenocarcinoma of the Lung? A Quantitative Review Using The Negative Exponential Model; Regul. Toxicol. Pharmacol. 72 (2015) 49-57.Search in Google Scholar

17. Simonato, L., A. Agudo, W. Ahrens, E. Benhamou, S. Benhamou, P. Boffetta, P. Brennan, S.C. Darby, F. Forastiere, C. Fortes, V. Gaborieau, M. Gerken, C.A. Gonzales, K.-H. Jöckel, M. Kreuzer, F. Merletti, F. Nyberg, G. Pershagen, H. Pohlabeln, F. Rösch, E. Whitley, H.-E. Wichmann, and P. Zambon: Lung Cancer and Cigarette Smoking in Europe: An Update of Risk Estimates and an Assessment of Inter-Country Heterogeneity; Int. J. Cancer 91 (2001) 876-887.Search in Google Scholar

18. Vogelstein, B. and K.W. Kinzler: Cancer Genes and the Pathways they Control; Nat. Med. 10 (2004) 789-799.Search in Google Scholar

19. Vineis, P. and D. Kriebel: Causal Models in Epidemiology: Past Inheritance and Genetic Future; Environ. Health 5 (2006) 21.Search in Google Scholar

20. Kerr, K.M.: Clinical Relevance of the New IASLC / ERS / ATS Adenocarcinoma Classification; J. Clin. Pathol. 66 (2013) 832-838. Search in Google Scholar

21. Mundt, K.A., C. Bigelow, and E. van Wijngaarden: Apportionment of Disease in Individuals; J. Clin. Epidemiol. 56 (2003) 290-291; author reply 291.10.1016/S0895-4356(02)00594-2Search in Google Scholar

22. Rothman, K.J. and S. Greenland: Causation and Causal Inference in Epidemiology; Am. J. Public Health 95 Suppl 1 (2005) S144-150.10.2105/AJPH.2004.05920416030331Search in Google Scholar

23. Greenland, S. and J.M. Robins: Epidemiology, Justice, and the Probability of Causation; Jurimetrics 40 (2000) 321-340.Search in Google Scholar

24. Peto, R., S. Darby, H. Deo, P. Silcocks, E. Whitley, and R. Doll: Smoking, Smoking Cessation, and Lung Cancer in the UK since 1950: Combination of National Statistics with Two Case-Control Studies; BMJ 321 (2000) 323-329.Search in Google Scholar

25. International Agency for Research on Cancer (IARC): Tobacco Control: Reversal of Risk After Quitting Smoking; IARC Handbooks of Cancer Prevention, Volume 11, IARC Press, Lyon, France, 2007.Search in Google Scholar

26. Doll, R., R. Peto, J. Boreham, and I. Sutherland: Mortality in Relation to Smoking: 50 Years’ Observations on Male British Doctors; BMJ 328 (2004) 1519.Search in Google Scholar

27. Khuder, S.A. and A.B. Mutgi: Effect of Smoking Cessation on Major Histologic Types of Lung Cancer; Chest 120 (2001) 1577-1583.Search in Google Scholar

28. Speizer, F.E., G.A. Colditz, D.J. Hunter, B. Rosner, and C. Hennekens: Prospective Study of Smoking, Antioxidant Intake, and Lung Cancer in Middle-Aged Women (USA); Cancer Causes Control 10 (1999) 475-482.Search in Google Scholar

29. Ebbert, J.O., P. Yang, C.M. Vachon, R.A. Vierkant, J.R. Cerhan, A.R. Folsom, and T.A. Sellers: Lung Cancer Risk Reduction After Smoking Cessation: Observations from a Prospective Cohort of Women; J. Clin. Oncol. 21 (2003) 921-926.Search in Google Scholar

30. Flanders, W.D., C.A. Lally, B.-P. Zhu, S.J. Henley, and M.J. Thun: Lung Cancer Mortality in Relation to Age, Duration of Smoking, and Daily Cigarette Consumption: Results from Cancer Prevention Study II; Cancer Res. 63 (2003) 6556-6562.Search in Google Scholar

31. Lubin, J.H. and N.E. Caporaso: Cigarette Smoking and Lung Cancer: Modeling Total Exposure and Intensity; Cancer Epidemiol. Biomarkers Prev. 15 (2006) 517-523.Search in Google Scholar

32. Govindan, R., L. Ding, M. Griffith, J. Subramanian, N.D. Dees, K.L. Kanchi, C.A. Maher, R. Fulton, L. Fulton, J. Wallis, K. Chen, J. Walker, S. McDonald, R. Bose, D. Ornitz, D. Xiong, M. You, D.J. Dooling, M. Watson, E.R. Mardis, and R.K. Wilson: Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers; Cell 150 (2012) 1121-1134. Search in Google Scholar

33. Li, F., Y. Feng, R. Fang, Z. Fang, J. Xia, X. Han, X.-Y. Liu, H. Chen, H. Liu, and H. Ji: Identification of RET Gene Fusion by Exon Array Analyses in "Pan-Negative" Lung Cancer from Never Smokers; Cell Res. 22 (2012) 928-931.Search in Google Scholar

34. Sun, S., J.H. Schiller, and A.F. Gazdar: Lung Cancer in Never Smokers--A Different Disease; Nat. Rev. Cancer 7 (2007) 778-790.Search in Google Scholar

35. Ou, S.-H.: Lung Cancer in Never-Smokers. Does Smoking History Matter in the Era of Molecular Diagnostics and Targeted Therapy?; J. Clin. Pathol. 66 (2013) 839-846.Search in Google Scholar

36. Staaf, J., G. Jönsson, M. Jönsson, A. Karlsson, S. Isaksson, A. Salomonsson, H.M. Pettersson, M. Soller, S.B. Ewers, L. Johansson, P. Jönsson, and M. Planck: Relation between Smoking History and Gene Expression Profiles in Lung Adenocarcinomas; BMC Med Genomics 5 (2012) 22.Search in Google Scholar

37. Noguchi, M., A. Morikawa, M. Kawasaki, Y. Matsuno, T. Yamada, S. Hirohashi, H. Kondo, and Y. Shimosato: Small Adenocarcinoma of the Lung. Histologic Characteristics and Prognosis; Cancer 75 (1995) 2844-2852.Search in Google Scholar

38. Colby, T., M. Noguchi, and C. Henschke: Adenocarcinoma; in: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart; 3rd ed., edited by W.B. Travis, E. Brambilla, H.K. Müller-Hermlink, and C.C. Harris, International Agency for Research on Cancer, Lyon, France, 2004, pp 35-44.Search in Google Scholar

39. Motoi, N., J. Szoke, G.J. Riely, V.E. Seshan, M.G. Kris, V.W. Rusch, W.L. Gerald, and W.D. Travis: Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis; Am. J. Surg. Pathol. 32 (2008) 810-827.Search in Google Scholar

40. Nassar, H.: Carcinomas with Micropapillary Morphology: Clinical Significance and Current Concepts; Adv. Anat. Pathol. 11 (2004) 297-303. Search in Google Scholar

41. Rekhtman, N., P.K. Paik, M.E. Arcila, L.J. Tafe, G.R. Oxnard, A.L. Moreira, W.D. Travis, M.F. Zakowski, M.G. Kris, and M. Ladanyi: Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations; Clin. Cancer Res. 18 (2012) 1167-1176.Search in Google Scholar

42. Dogan, S., R. Shen, D.C. Ang, M.L. Johnson, S.P. D’Angelo, P.K. Paik, E.B. Brzostowski, G.J. Riely, M.G. Kris, M.F. Zakowski, and M. Ladanyi: Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers; Clin. Cancer Res. 18 (2012) 6169-6177. Search in Google Scholar

43. Girard, N., C.S. Sima, D.M. Jackman, L.V. Sequist, H. Chen, J.C.-H. Yang, H. Ji, B. Waltman, R. Rosell, M. Taron, M.F. Zakowski, M. Ladanyi, G. Riely, and W. Pao: Nomogram to Predict the Presence of EGFR Activating Mutation in Lung Adenocarcinoma; Eur. Respir. J. 39 (2012) 366-372.Search in Google Scholar

44. Imielinski, M., A.H. Berger, P.S. Hammerman, B. Hernandez, T.J. Pugh, E. Hodis, J. Cho, J. Suh, M. Capelletti, A. Sivachenko, C. Sougnez, D. Auclair, M.S. Lawrence, P. Stojanov, K. Cibulskis, K. Choi, L. de Waal, T. Sharifnia, A. Brooks, H. Greulich, S.Banerji, T. Zander, D. Seidel, F. Leenders, S. Ansén, C.Ludwig, W. Engel-Riedel, E. Stoelben, J. Wolf, C. Goparju, K. Thompson, W. Winckler, D. Kwiatkowski, B.E. Johnson, P.A. Jänne, V.A. Miller, W. Pao, W.D. Travis, H.I. Pass, S.B. Gabriel, E.S. Lander, R.K. Thomas, L.A. Garraway, G. Getz, and M. Meyerson: Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing; Cell 150 (2012) 1107-1120.Search in Google Scholar

45. Kris, M.G., B.E. Johnson, L.D. Berry, D.J. Kwiat Kwiatkowski, A.J. Iafrate, I.I. Wistuba, M. Varella-Garcia, W.A. Franklin, S.L. Aronson, P.-F. Su, Y. Shyr, D.R. Camidge, L.V. Sequist, B.S. Glisson, F.R. Khuri, E.B. Garon, W. Pao, C. Rudin, J. Schiller, E.B. Haura, M. Socinski, K. Shirai, H. Chen, G. Giaccone, M. Ladanyi, K. Kugler, J.D. Minna, and P.A. Bunn: Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs; JAMA 311 (2014) 1998-2006.Search in Google Scholar

46. Lindeman, N.I., P.T. Cagle, M.B. Beasley, D.A. Chitale, S. Dacic, G. Giaccone, R.B. Jenkins, D.J. Kwiatkowski, J.-S. Saldivar, J. Squire, E. Thunnissen, and M. Ladanyi: Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology; Arch. Pathol. Lab. Med. 137 (2013) 828-860.Search in Google Scholar

47. Shigematsu, H., L. Lin, T. Takahashi, M. Nomura, M. Suzuki, I.I. Wistuba, K.M. Fong, H. Lee, S. Toyooka, N. Shimizu, T. Fujisawa, Z. Feng, J.A. Roth, J. Herz, J.D. Minna, and A.F. Gazdar: Clinical and Biological Features Associated with Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers; J. Natl. Cancer Inst. 97 (2005) 339-346.Search in Google Scholar

48. Kim, H.R., J.R. Ahn, J.G. Lee, D.H. Bang, S.-J. Ha, Y.K. Hong, S.M. Kim, K.C. Nam, S.Y. Rha, R.A. Soo, G.J. Riely, J.H. Kim, and B.C. Cho: The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma; Yonsei Med. J. 54 (2013) 865-874.Search in Google Scholar

49. Kim, H.R., H.S. Shim, J.-H. Chung, Y.J. Lee, Y.K. Hong, S.Y. Rha, S.H. Kim, S.-J. Ha, S.K. Kim, K.Y. Chung, R. Soo, J.H. Kim, and B.C. Cho: Distinct Clinical Features and Outcomes in Never-Smokers with Nonsmall Cell Lung Lancer who Harbor EGFR or KRAS Mutations or ALK rearrangement; Cancer 118 (2012) 729-739.Search in Google Scholar

50. Riely, G.J., M.G. Kris, D. Rosenbaum, J. Marks, A. Li, D.A. Chitale, K. Nafa, E.R. Riedel, M. Hsu, W. Pao, V.A. Miller, and M. Ladanyi: Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma; Clin. Cancer Res. 14 (2008) 5731-5734.Search in Google Scholar

51. Riely, G.J., J. Marks, and W. Pao: KRAS Mutations in Non-Small Cell Lung Cancer; Proc. Am. Thorac. Soc. 6 (2009) 201-205.Search in Google Scholar

52. Smits, A.J.J., J.A. Kummer, J.W.J. Hinrichs, G.J.M. Herder, K.C. Scheidel-Jacobse, N.M. Jiwa, T.E.G. Ruijter, P.T.G.A. Nooijen, M.G. Looijen-Salamon, M.J.L. Ligtenberg, F.B. Thunnissen, D.A.M. Heideman, R.A. de Weger, and A. Vink: EGFR and KRAS Mutations in Lung Carcinomas in the Dutch Population: Increased EGFR Mutation Frequency in Malignant Pleural Effusion of Lung Adenocarcinoma; Cell. Oncol. 35 (2012) 189-196.Search in Google Scholar

53. Cardarella, S., A. Ogino, M. Nishino, M. Butaney, J. Shen, C. Lydon, B.Y. Yeap, L.M. Sholl, B.E. Johnson, and P.A. Jänne: Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non- Small Cell Lung Cancer; Clin. Cancer Res. 19 (2013) 4532-4540.Search in Google Scholar

54. Marchetti, A., L. Felicioni, S. Malatesta, M. Grazia Sciarrotta, L. Guetti, A. Chella, P. Viola, C. Pullara, F. Mucilli, and F. Buttitta: Clinical Features and Outcome of Patients with Non-Small-Cell Lung Cancer Harboring BRAF Mutations; J. Clin. Oncol. 29 (2011) 3574-3579. Search in Google Scholar

55. Paik, P.K., M.E. Arcila, M. Fara, C.S. Sima, V.A. Miller, M.G. Kris, M. Ladanyi, and G.J. Riely: Clinical Characteristics of Patients with Lung Adenocarcinomas Harboring BRAF Mutations; J. Clin. Oncol. 29 (2011) 2046-2051.Search in Google Scholar

56. Sasaki, H., M. Shitara, K. Yokota, K. Okuda, Y. Hikosaka, S. Moriyama, M. Yano, and Y. Fujii: Braf and erbB2 Mutations Correlate with Smoking Status in Lung Cancer Patients; Exp. Ther. Med. 3 (2012) 771-775.Search in Google Scholar

57. Arcila, M.E., J.E. Chaft, K. Nafa, S. Roy-Chowdhuri, C. Lau, M. Zaidinski, P.K. Paik, M.F. Zakowski, M.G. Kris, and M. Ladanyi: Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas; Clin. Cancer Res. 18 (2012) 4910-4918.Search in Google Scholar

58. Mazières, J., S. Peters, B. Lepage, A.B. Cortot, F. Barlesi, M. Beau-Faller, B. Besse, H. Blons, A. Mansuet-Lupo, T. Urban, D. Moro-Sibilot, E. Dansin, C. Chouaid, M. Wislez, J. Diebold, E. Felip, I. Rouquette, J.D. Milia, and O. Gautschi: Lung Cancer that Harbors a HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives; J. Clin. Oncol. 31 (2013) 1997-2003.Search in Google Scholar

59. Shigematsu, H., T. Takahashi, M. Nomura, K. Majmudar, M. Suzuki, H. Lee, I.I. Wistuba, K.M. Fong, S. Toyooka, N. Shimizu, T. Fujisawa, J.D. Minna, and A.F. Gazdar: Somatic Mutations of the HER2 Kinase Domain in Lung Adenocarcinomas; Cancer Res. 65 (2005) 1642-1646.Search in Google Scholar

60. Sonobe, M., T. Manabe, H. Wada, and F. Tanaka: Lung Adenocarcinoma Harboring Mutations in the ERBB2 Kinase Domain; J. Mol. Diagn. 8 (2006) 351-356.Search in Google Scholar

61. Bergethon, K., A.T. Shaw, S.-H.I. Ou, R. Katayama, C.M. Lovly, N.T. McDonald, P.P. Massion, C. Siwak- Tapp, A. Gonzalez, R. Fang, E.J. Mark, J.M. Batten, H. Chen, K.D. Wilner, E.L. Kwak, J.W. Clark, D.P. Carbone, H. Ji, J.A. Engelman, M. Mino-Kenudson, W. Pao, and A.J. Iafrate: ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers; J. Clin. Oncol. 30 (2012) 863-870.Search in Google Scholar

62. Cha, Y.J., J.S. Lee, H.R. Kim, S.M. Lim, B.C. Cho, C.Y. Lee, and H.S. Shim: Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements; PLoS ONE 9 (2014) e103333.Search in Google Scholar

63. Shan, L., F. Lian, L. Guo, T. Qiu, Y. Ling, J. Ying, and D. Lin: Detection of ROS1 Gene Rearrangement in Lung Adenocarcinoma: Comparison of IHC, FISH and Real-Time RT-PCR; PLoS ONE 10 (2015) e0120422.Search in Google Scholar

64. Lee, S.E., B. Lee, M. Hong, J.-Y. Song, K. Jung, M.E. Lira, M. Mao, J. Han, J. Kim, and Y.L. Choi: Comprehensive Analysis of RET and ROS1 Rearrangement in Lung Adenocarcinoma; Mod. Pathol. 28 (2015) 468-479. Search in Google Scholar

65. Yokota, K., H. Sasaki, K. Okuda, S. Shimizu, M. Shitara, Y. Hikosaka, S. Moriyama, M. Yano, and Y. Fujii: KIF5B/RET Fusion Gene in Surgically-Treated Adenocarcinoma of the Lung; Oncol. Rep. 28 (2012) 1187-1192.Search in Google Scholar

66. Kim, H. and J.-H. Chung: Overview of Clinicopathologic Features of ALK-Rearranged Lung Adenocarcinoma and Current Diagnostic Testing for ALK Rearrangement; Transl. Lung Cancer Res. 4 (2015) 149-155.Search in Google Scholar

67. Koh, Y., D.-W. Kim, T.M. Kim, S.-H. Lee, Y.K. Jeon, D.H. Chung, Y.-W. Kim, D.S. Heo, W.-H. Kim, and Y.-J. Bang: Clinicopathologic Characteristics and Outcomes of Patients with Anaplastic Lymphoma Kinase- Positive Advanced Pulmonary Adenocarcinoma: Suggestion for an Effective Screening Strategy for these Tumors; J. Thorac. Oncol. 6 (2011) 905-912.Search in Google Scholar

68. Li, Y., Y. Li, T. Yang, S. Wei, J. Wang, M. Wang, Y. Wang, Q. Zhou, H. Liu, and J. Chen: Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer; PLoS ONE 8 (2013) e52093.Search in Google Scholar

69. Oxnard, G.R., K.-S. Nguyen, and D.B. Costa: Germline Mutations in Driver Oncogenes and Inherited Lung Cancer Risk Independent of Smoking History; J. Natl. Cancer Inst. 106 (2014) djt361.10.1093/jnci/djt36124317178Search in Google Scholar

70. Wang, Y., S. Wang, S. Xu, J. Qu, and B. Liu: Clinicopathologic Features of Patients with Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Gene: A Meta-Analysis; PLoS ONE 9 (2014) e110617.Search in Google Scholar

71. Lynch, T.J., D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, F.G. Haluska, D.N. Louis, D.C. Christiani, J. Settleman, and D.A. Haber: Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small- Cell Lung Cancer to Gefitinib; N. Engl. J. Med. 350 (2004) 2129-2139.Search in Google Scholar

72. Paez, J.G., P.A. Jänne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, and M. Meyerson: EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy; Science 304 (2004) 1497-1500.Search in Google Scholar

73. Pao, W., V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, B. Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, D. Kupfer, R. Wilson, M. Kris, and H. Varmus: EGF Receptor Gene Mutations are Common in Lung Cancers from "Never Smokers" and are Associated with Sensitivity of Tumors to Gefitinib and Erlotinib; Proc. Natl. Acad. Sci. U S A 101 (2004) 13306-13311.Search in Google Scholar

74. D’Angelo, S.P., M.C. Pietanza, M.L. Johnson, G.J. Riely, V.A. Miller, C.S. Sima, M.F. Zakowski, V.W. Rusch, M. Ladanyi, and M.G. Kris: Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens from Men and Cigarette Smokers with Lung Adenocarcinomas; Clin. Oncol. 29 (2011) 2066-2070.Search in Google Scholar

75. Thu, K.L., E.A. Vucic, R. Chari, W. Zhang, W.W. Lockwood, J.C. English, R. Fu, P. Wang, Z. Feng, C.E. MacAulay, .F. Gazdar, S. Lam, and W.L. Lam: Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability; PLoS ONE 7 (2012) e33003.Search in Google Scholar

76. Leary, A.F., D. Gonsalez de Castro, A.G. Nicholson, S. Ashley, A. Wotherspoon, M.E.R. O’Brien, and S. Popat: Establishing an EGFR Mutation Screening Service for Non-Small Cell Lung Cancer - Sample Quality Criteria and Candidate Histological Predictors; Eur. J. Cancer 48 (2012) 61-67.Search in Google Scholar

77. Li, H., Y. Pan, Y. Li, C. Li, R. Wang, H. Hu, Y. Zhang, T. Ye, L. Wang, L. Shen, Y. Sun, and H. Chen: Frequency of Well-Identified Oncogenic Driver Mutations in Lung Adenocarcinoma of Smokers Varies with Histological Subtypes and Graduated Smoking Dose; Lung Cancer 79 (2013) 8-13.Search in Google Scholar

78. Jänne, P.A., A.T. Shaw, J.R. Pereira, G. Jeannin, J. Vansteenkiste, C. Barrios, F.A. Franke, L. Grinsted, V. Zazulina, P. Smith, I. Smith, and L. Crinò: Selumetinib plus Docetaxel for KRAS-Mutant Advanced Non- Small-Cell Lung Cancer: A Randomised, Multicentre, Placebo-Controlled, Phase 2 Study; Lancet Oncol. 14 (2013) 38-47.Search in Google Scholar

79. Tsuta, K., M. Kawago, E. Inoue, A. Yoshida, F. Takahashi, H. Sakurai, S.-I. Watanabe, M. Takeuchi, K. Furuta, H. Asamura, and H. Tsuda: The Utility of the Proposed IASLC/ATS/ERS Lung Adenocarcinoma Subtypes for Disease Prognosis and Correlation of Driver Gene Alterations; Lung Cancer 81 (2013) 371-376.Search in Google Scholar

80. Maeda, R., G. Ishii, J. Yoshida, T. Hishida, M. Nishimura, and K. Nagai: Influence of Cigarette Smoking on Histological Subtypes of Stage I Lung Adenocarcinoma; J. Thorac. Oncol. 6 (2011) 743-750.Search in Google Scholar

81. Sakao, Y., H. Miyamoto, S. Oh, N. Takahashi, T.Inagaki, Y. Miyasaka, T. Akaboshi, and M. Sakuraba: The Impact of Cigarette Smoking on Prognosis in Small Adenocarcinomas of the Lung: The Association between Histologic Subtype and Smoking Status; J.Thorac. Oncol. 3 (2008) 958-962.Search in Google Scholar

82. Hu, H., Y. Pan, Y. Li, L. Wang, R. Wang, Y. Zhang, H. Li, T. Ye, Y. Zhang, X. Luo, L. Shao, Z. Sun, D. Cai, J. Xu, Q. Lu, Y. Deng, L. Shen, H. Ji, Y. Sun, and H. Chen: Oncogenic Mutations Are Associated with Histological Subtypes but do Not Have an Independent Prognostic Value in Lung Adenocarcinoma; Onco. Targets Ther. 7 (2014) 1423-1437.Search in Google Scholar

83. Miyoshi, T., Y. Satoh, S. Okumura, K. Nakagawa, T. Shirakusa, E. Tsuchiya, and Y. Ishikawa: Early-Stage Lung Adenocarcinomas with a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor Prognosis; Am. J. Surg. Pathol. 27 (2003) 101-109.Search in Google Scholar

84. Villa, C., P.T. Cagle, M. Johnson, J.D. Patel, A.V. Yeldandi, R. Raj, M.M. DeCamp, and K. Raparia: Correlation of EGFR Mutation Status with Predominant Histologic Subtype of Adenocarcinoma According to the New Lung Adenocarcinoma Classification of the International Association for the Study of Lung Cancer/ American Thoracic Society/European Respiratory Society; Arch. Pathol. Lab. Med. 138 (2014) 1353-1357.Search in Google Scholar

85. An, S.-J., Z.-H. Chen, J. Su, X.-C. Zhang, W.-Z. Zhong, J.-J. Yang, Q. Zhou, X.-N. Yang, L. Huang, J.- L. Guan, Q. Nie, H.-H. Yan, T.S. Mok, and Y.-L. Wu: Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status; PLoS ONE 7 (2012) e40109.Search in Google Scholar

86. Huang, S.-F., H.-P. Liu, L.-H. Li, Y.-C. Ku, Y.-N. Fu, H.-Y. Tsai, Y.-T. Chen, Y.-F. Lin, W.-C. Chang, H.-P. Kuo, Y.-C. Wu, Y.-R. Chen, and S.-F. Tsai: High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non-Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan; Clin. Cancer Res. 10 (2004) 8195-8203.Search in Google Scholar

87. Yano, T., A. Haro, Y. Shikada, R. Maruyama, and Y. Maehara: Non-Small Cell Lung Cancer in Never Smokers as a Representative ’Non-Smoking-Associated Lung Cancer’: Epidemiology and Clinical Features; Int. J. Clin. Oncol. 16 (2011) 287-293.Search in Google Scholar

88. Paik, P.K., M.L. Johnson, S.P. D’Angelo, C.S. Sima, D. Ang, S. Dogan, V.A. Miller, M. Ladanyi, M.G. Kris, and G.J. Riely: Driver Mutations Determine Survival in Smokers and Never-Smokers with Stage IIIB/IV Lung Adenocarcinomas; Cancer 118 (2012) 5840-5847.Search in Google Scholar

89. Karlsson, A., M. Ringnér, M. Lauss, J. Botling, P. Micke, M. Planck, and J. Staaf: Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to Smoking History; Clin. Cancer Res. 20 (2014) 4912-4924.Search in Google Scholar

90. Krishnan, V.G., P.J. Ebert, J.C. Ting, E. Lim, S.-S. Wong, A.S.M. Teo, Y.G. Yue, H.-H. Chua, X. Ma, G.S.L. Loh, Y. Lin, J.H.J. Tan, K. Yu, S. Zhang, C.Reinhard, D.S.W. Tan, B.A. Peters, S.E. Lincoln, D.G.Ballinger, J.M. Laramie, G.B. Nilsen, T.D. Barber, P.Tan, A.M. Hillmer, and P.C. Ng: Whole-Genome Sequencing of Asian Lung Cancers: Second-Hand Smoke Unlikely to be Responsible for Higher Incidence of Lung Cancer Among Asian Never-Smokers; Cancer Res. 74 (2014) 6071-6081.Search in Google Scholar

91. Tomashefski, J.F., Jr, P.T. Cagle, C.F. Farver, and A.E. Fraire: Dail and Hammar’s Pulmonary Pathology, Vol. II, Neoplastic Lung Disease, 3rd ed.; Springer, New York, NY, 2010. Search in Google Scholar

92. Sato, S., N. Motoi, M. Hiramatsu, E. Miyauchi, H.Search in Google Scholar

Ono, Y. Saito, H. Nagano, H. Ninomiya, K. Inamura, H. Uehara, M. Mun, Y. Sakao, S. Okumura, M. Tsuchida, and Y. Ishikawa: Pulmonary Adenocarcinoma in Situ: Analyses of a Large Series with Reference to Smoking, Driver Mutations, and Receptor Tyrosine Kinase Pathway Activation; Am. J. Surg. Pathol. 39 (2015) 912-921. Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo